Behind the markets

Blog

UPDATE: Krystal Biotech & Schrodinger Up Big Today – what to do

Lot's of folks writing in today, so I figured I'd send this note to the whole group instead of to one member at a time. 

UPDATE: Krystal Bio hits all-time high on FDA approval

Krystal Biotech (SYM: KRYS) hit an all-time high today of $95 on winning FDA approval of Vyjuvek, a topical gene therapy for dystrophic epidermolysis bullosa (DEB).

August 2022 Issue: Krystal Biotech (NAS:KRYS)

Investors may want to keep an eye on the biotech boom. For one, the sector is still one of the safest, most recession-proof investments around.

UPDATE: Krystal Biotech & Schrodinger Up Big Today – what to do

Lot's of folks writing in today, so I figured I'd send this note to the whole group instead of to one member at a time. 

UPDATE: Krystal Bio hits all-time high on FDA approval

Krystal Biotech (SYM: KRYS) hit an all-time high today of $95 on winning FDA approval of Vyjuvek, a topical gene therapy for dystrophic epidermolysis bullosa (DEB).

August 2022 Issue: Krystal Biotech (NAS:KRYS)

Investors may want to keep an eye on the biotech boom. For one, the sector is still one of the safest, most recession-proof investments around.

Categories

Recent posts

Tags

Connect with Us

Get FREE Weekly Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*

You applied for

Hidden Market Profits

Platinum

$99

This field is for validation purposes and should be left unchanged.